Investment
Features
FeesSafety
Academy
More
Pluang+

AIxCrypto to acquire FFAI's robotics business, rebrand as FF EAI Robotics, focusing fully on AI robotics by 2026

Company Fundamentals
28 Sep 2026
PRNewsWire
View Source
Bullish
AIxCrypto to acquire FFAI's robotics business, rebrand as FF EAI Robotics, focusing fully on AI robotics by 2026

AIxCrypto Holdings plans to acquire Faraday Future Intelligent Electric's robotics business for about $200 million in stock, aiming to become the first Nasdaq-listed pure-play robotics ecosystem company. The deal, approved by both companies' boards, will transform AIxCrypto into FF EAI Robotics Ecosystem Inc. with a ticker change to FFR by September 30, 2026. This marks AIxCrypto's exit from crypto to focus solely on robotics, targeting a top-three market position in the EAI robotics ecosystem within five years. The robotics business has shown strong early growth, with 24 products launched and positive gross margins, and projects nearly $2 billion revenue over five years. The transaction is subject to final agreements and approvals.

AIxCrypto Holdings' planned $200 million robotics acquisition comes as 42 of 150 Technology-sector US stocks on Pluang rose while 107 fell. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 29, 2026 03:41 WIB: QCOM traded at USD 187.51 with a 7.11% decline and 77% buy order activity, DUOL at USD 134.30 down 6.42% with 88% buy orders, and FSLY at USD 24.98 down 6.37% with 91% buy orders. Typical hold times ranged from 26 to 135 days.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
2 hours ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
2 hours ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
3 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
3 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App